Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of December 20, 2024 • 12:00 AM ET
As of December 20, 2024 • 12:00 AM ET
Date/Time | Source | News Release |
---|---|---|
12/04/2024 06:00 AM EST | US Earnings Reports | Expected US Company Earnings on Wednesday, December 4th, 2024 |
12/04/2024 04:31 AM EST | US Earnings Reports | Expected earnings - Revive Therapeutics Ltd |
11/06/2024 01:55 AM EST | SeekingAlpha | Massachusetts psychedelics legalization initiative poised to fail |
11/04/2024 05:27 AM EST | SeekingAlpha | Legalizing psychedelics: Is Massachusetts next? |
10/19/2024 09:40 AM EDT | SeekingAlpha | FDA is said to see "path forward" for ecstasy-based drug |
10/16/2024 01:55 PM EDT | SeekingAlpha | Bright Minds rally ends as psychedelic stocks extend volatility |
09/18/2024 07:09 AM EDT | SeekingAlpha | Revive Therapeutics to focus on Bucillamine |
06/05/2024 07:17 AM EDT | SeekingAlpha | Psychedelic stocks fall as FDA panel rejects MDMA therapy |
06/01/2024 05:38 AM EDT | US Earnings Reports | Expected earnings - Revive Therapeutics Ltd |
05/31/2024 10:43 AM EDT | SeekingAlpha | Psychedelic stocks mixed as FDA comments on MDMA therapy |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.